Zenotech Lab.

{
  "main_header": {
    "sid": 683231,
    "name": "Zenotech Lab.",
    "stock_name": "Zenotech Lab.",
    "full_name": "Zenotech Laboratories Ltd",
    "name_url": "stocks-analysis/zenotech-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "45.17",
    "chg": 1.77,
    "chgp": "4.08%",
    "dir": 1,
    "prev_price": "43.40",
    "mcapval": "272.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532039,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE486F01012",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "11.39 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zenotech-lab-683231-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zenotech Laboratories Downgraded to Strong Sell Amidst Deteriorating Financial and Technical Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-downgraded-to-strong-sell-amidst-deteriorating-financial-and-technical-indicators-3975257",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZenotechLaborat_mojoScore_3975257.png",
        "date": "2026-05-05 08:41:45",
        "description": "Zenotech Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating following a marked deterioration in its financial performance, valuation metrics, and technical indicators. The pharmaceutical company’s quarterly results for March 2026 reveal significant declines in profitability and sales, while technical trends have shifted to bearish, signalling increased caution for investors."
      },
      {
        "title": "Zenotech Laboratories Falls 4.15%: Quarterly Profit Decline and Sector Challenges Weigh",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-falls-415-quarterly-profit-decline-and-sector-challenges-weigh-3971701",
        "imagepath": "",
        "date": "2026-05-02 16:03:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Apr 27:</strong> Stock opens strong at Rs.46.70 (+2.64%) amid positive market sentiment</p>\n                    <p><strong>Apr 28:</strong> Sharp correction to Rs.45.43 (-2.72%) following profit-taking</p>\n                    <p><strong>Apr 29:</strong> Q4 FY26 results reveal sharp profit decline, stock marginally up at Rs.45.53 (+0.22%)</p>\n                    <p><strong>Apr 30:</strong> Further decline to Rs.43.61 (-4.22%) as quarterly financial performance disappoints amid sector challenges</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.45.50</div></..."
      },
      {
        "title": "Are Zenotech Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-zenotech-laboratories-ltd-latest-results-good-or-bad-3970737",
        "imagepath": "",
        "date": "2026-04-30 19:16:27",
        "description": "Zenotech Laboratories Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported net sales of ₹8.87 crores, which represents a notable decline of 25.02% compared to the previous quarter and a year-on-year decrease of 20.16%. This marks the lowest quarterly revenue in the past seven quarters, indicating potential issues with market demand or competitive positioning.\n\nThe net profit for the quarter was ₹-3.15 crores, a dramatic shift from a profit of ₹1.93 crores in the prior quarter, highlighting a substantial deterioration in profitability. The operating margin fell sharply to 2.03%, down from 36.09% in the previous quarter, indicating severe operational stress and inefficiencies. Additionally, the profit after tax (PAT) margin turned negative at -35.51%, contrasting with a positive margin of 16.31% just one quarter earlier.\n\nThe financial performance suggest..."
      },
      {
        "title": "Zenotech Laboratories Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenotech-laboratories-ltd-reports-sharp-decline-in-quarterly-financial-performance-amid-sector-challenges-3969310",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZenotechLaborat_fintrenddot_3969310.png",
        "date": "2026-04-30 08:00:09",
        "description": "Zenotech Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a significant downturn in its financial performance for the quarter ended March 2026. The company’s key metrics, including net sales, profit after tax, and operating margins, have all deteriorated sharply compared to its recent historical averages, signalling a shift from positive to negative financial trends."
      },
      {
        "title": "Zenotech Laboratories Q4 FY26: Sharp Profit Decline Raises Concerns Over Operational Stability",
        "link": "https://www.marketsmojo.com/news/result-analysis/zenotech-laboratories-q4-fy26-sharp-profit-decline-raises-concerns-over-operational-stability-3969249",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZenotechLaborat_quaterlyResult_3969249.png",
        "date": "2026-04-29 22:31:10",
        "description": "Zenotech Laboratories Ltd., a micro-cap pharmaceutical company specialising in generic injectables for oncology and anaesthesiology, reported a concerning quarter ending March 2026, with net profit plunging into negative territory at ₹-3.15 crores—a dramatic reversal from ₹1.93 crores in Q3 FY26. The company, with a market capitalisation of ₹281.00 crores, saw its stock trading at ₹45.53 as of April 29, 2026, reflecting a marginal 0.22% gain in the session following the results announcement, though the broader picture reveals significant underlying operational challenges."
      },
      {
        "title": "Zenotech Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-sell-3963215",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZenotechLaborat_mojoScore_3963215.png",
        "date": "2026-04-26 10:10:02",
        "description": "Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Zenotech Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-zenotech-laboratories-ltd-3961882",
        "imagepath": "",
        "date": "2026-04-24 23:15:59",
        "description": "The next results date for Zenotech Laboratories Ltd is scheduled for April 29, 2026...."
      },
      {
        "title": "Zenotech Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-sell-3947443",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZenotechLaborat_mojoScore_3947443.png",
        "date": "2026-04-15 10:10:03",
        "description": "Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Zenotech Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenotech-laboratories-ltd-is-rated-sell-3933070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZenotechLaborat_mojoScore_3933070.png",
        "date": "2026-04-04 10:10:02",
        "description": "Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      }
    ],
    "total": 135,
    "sid": "683231",
    "stock_news_url": "https://www.marketsmojo.com/news/zenotech-laboratories-683231"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Apr-2026",
      "details": "Copies of extract of Audited Standalone Financial Results of the Company for the quarter and financial year ended March 31 2026 as published in todays newspaper i.e. April 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On April 29 2026",
      "datetime": "29-Apr-2026",
      "details": "Submission of Audited Standalone Financial Results for the quarter and financial year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Audited Standalone Financial Results For The Quarter And Financial Year Ended March 31 2026",
      "datetime": "29-Apr-2026",
      "details": "Audited Standalone Financial Results for the quarter and financial year ended March 31 2026 and declaration of unmodified opinion on the Financial Results.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Zenotech Laboratories Ltd has announced <strong>17:22</strong> rights issue, ex-date: 01 Jun 17",
          "dt": "2017-06-01",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Zenotech Laboratories Downgraded to Strong Sell Amidst Deteriorating Financial and Technical Indicators

2026-05-05 08:41:45

Zenotech Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating following a marked deterioration in its financial performance, valuation metrics, and technical indicators. The pharmaceutical company’s quarterly results for March 2026 reveal significant declines in profitability and sales, while technical trends have shifted to bearish, signalling increased caution for investors.

Read full news article

Zenotech Laboratories Falls 4.15%: Quarterly Profit Decline and Sector Challenges Weigh

2026-05-02 16:03:16

Key Events This Week

Apr 27: Stock opens strong at Rs.46.70 (+2.64%) amid positive market sentiment

Apr 28: Sharp correction to Rs.45.43 (-2.72%) following profit-taking

Apr 29: Q4 FY26 results reveal sharp profit decline, stock marginally up at Rs.45.53 (+0.22%)

Apr 30: Further decline to Rs.43.61 (-4.22%) as quarterly financial performance disappoints amid sector challenges

Week Open

Rs.45.50

Read full news article

Are Zenotech Laboratories Ltd latest results good or bad?

2026-04-30 19:16:27

Zenotech Laboratories Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported net sales of ₹8.87 crores, which represents a notable decline of 25.02% compared to the previous quarter and a year-on-year decrease of 20.16%. This marks the lowest quarterly revenue in the past seven quarters, indicating potential issues with market demand or competitive positioning. The net profit for the quarter was ₹-3.15 crores, a dramatic shift from a profit of ₹1.93 crores in the prior quarter, highlighting a substantial deterioration in profitability. The operating margin fell sharply to 2.03%, down from 36.09% in the previous quarter, indicating severe operational stress and inefficiencies. Additionally, the profit after tax (PAT) margin turned negative at -35.51%, contrasting with a positive margin of 16.31% just one quarter earlier. The financial performance suggest...

Read full news article

Zenotech Laboratories Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Sector Challenges

2026-04-30 08:00:09

Zenotech Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a significant downturn in its financial performance for the quarter ended March 2026. The company’s key metrics, including net sales, profit after tax, and operating margins, have all deteriorated sharply compared to its recent historical averages, signalling a shift from positive to negative financial trends.

Read full news article

Zenotech Laboratories Q4 FY26: Sharp Profit Decline Raises Concerns Over Operational Stability

2026-04-29 22:31:10

Zenotech Laboratories Ltd., a micro-cap pharmaceutical company specialising in generic injectables for oncology and anaesthesiology, reported a concerning quarter ending March 2026, with net profit plunging into negative territory at ₹-3.15 crores—a dramatic reversal from ₹1.93 crores in Q3 FY26. The company, with a market capitalisation of ₹281.00 crores, saw its stock trading at ₹45.53 as of April 29, 2026, reflecting a marginal 0.22% gain in the session following the results announcement, though the broader picture reveals significant underlying operational challenges.

Read full news article

Zenotech Laboratories Ltd is Rated Sell

2026-04-26 10:10:02

Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

When is the next results date for Zenotech Laboratories Ltd?

2026-04-24 23:15:59

The next results date for Zenotech Laboratories Ltd is scheduled for April 29, 2026....

Read full news article

Zenotech Laboratories Ltd is Rated Sell

2026-04-15 10:10:03

Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Zenotech Laboratories Ltd is Rated Sell

2026-04-04 10:10:02

Zenotech Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

View All News